Esophageal Squamous Cell Carcinoma (ESCC)

60 clinical trials · Condition

Sort:Newest first Oldest first

◉ Watch Esophageal Squamous Cell Carcinoma (ESCC)

Record	Firm	Date
BI-754091 and Afatinib for Refractory Esophageal Squamous Cell Carcinoma (BEAR Study) (NCT04839471)	National Health Research Institutes, Taiwan	2021-08-06
An Observational Study on the Safety and Efficacy of Immunotherapy Combined With Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (NCT07080437)	Three Gorges Hospital of Chongqing University	2021-03-01
Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma (NCT07147361)	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	2020-05-28
A Study to Investigate Tislelizumab (BGB-A317) Versus Placebo in Combination With Concurrent Chemoradiotherapy in Participants With Localized Esophageal Squamous Cell Carcinoma (NCT03957590)	BeiGene	2019-06-11
A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma (NCT03783442)	BeiGene	2018-12-11
A Dose Escalation and Expansion Study of Lomvastomig, a PD-1/TIM-3 Bispecific Antibody, in Participants With Advanced and/or Metastatic Solid Tumors (NCT03708328)	Hoffmann-La Roche	2018-10-15
Neoadjuvant Immunochemotherapy vs Chemoradiotherapy in ESCC (NCT07236320)	Yongtao Han	2018-03-01
A Study of Tislelizumab (BGB-A317) Versus Chemotherapy as Second Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma (NCT03430843)	BeiGene	2018-01-26
Neoadjuvant Chemoradiotherapy Plus Surgery vs. Surgery Plus Adjuvant Therapy for ESCC (NCT06775652)	Yongtao Han	2018-01-01

Track Esophageal Squamous Cell Carcinoma (ESCC) automatically

Every clearance here is in the API, with alerts when new ones post.